243
Views
7
CrossRef citations to date
0
Altmetric
Human Biological Survey

Bosnian study of APOE distribution (BOSAD): a comparison with other European populations

, , , , , , & show all
Pages 568-573 | Received 11 Jul 2016, Accepted 23 May 2017, Published online: 13 Jul 2017

References

  • Adler G, Valjevac A, Skonieczna-Żydecka K, Mackic-Djurovic M, Parczewski M, Urbańska A, Salkic NN. 2014. Frequency of CCR5Δ32 allele in healthy Bosniak population. Bosn J Basic Med Sci 14:150–154.
  • Allen JS, Bruss J, Damasio H. 2005. The aging brain: the cognitive reserve hypothesis and hominid evolution. Am J Hum Biol 17:673–689.
  • Bailleul S, Couderc R, Landais V, Lefevre G, Raichvarg D, Etienne J. 1993. Direct phenotyping of human apolipoprotein E in plasma: application to population frequency distribution in Paris (France). Hum Hered 43:159–165.
  • Boerwinkle E, Sing CF. 1987. The use of measured genotype information in the analysis of quantitative phenotypes in man. III. Simultaneous estimation of the frequencies and effects of the apolipoprotein E polymorphism and residual polygenetic effects on cholesterol, betalipoprotein and triglyceride levels. Ann Hum Genet 51:211–226.
  • Borilova Linhartova P, Bartova J, Poskerova H, Machal J, Vokurka J, Fassmann A, Izakovicova Holla L. 2015. Apolipoprotein E gene polymorphisms in relation to chronic periodontitis, periodontopathic bacteria, and lipid levels. Arch Oral Biol 60:456–462.
  • Borinskaia SA, Kalina NR, Sanina ED, Kozhekbaeva ZM, Gupalo E, Garmash IV, Ogurtsov PP, et al. 2007. [Polymorphism of the apolipoprotein E gene (apo E) in the populations of Russia and neighboring countries.]. Genetika 43:1434–1440.
  • Braeckman L, de Bacquer D, Rosseneu M, de Backer G. 1996. Apolipoprotein E polymorphism in middle-aged Belgian men: phenotype distribution and relation to serum lipids and lipoproteins. Atherosclerosis 120:67–73.
  • Carioulou MA, Kokkofitou A, Manoli P, Christou S, Karagrigoriou A, Middleton L. 1995. Underexpression of the apolipoprotein E2 and EA alleles in a Greek Cypriot population of Cyprus. Genet Epidemiol 12:489–497.
  • Census 2013th official data. 2013. Available from: http://www.fzs.ba/eng/population.htm (accessed May, 2016).
  • Conejero-Goldberg C, Gomar JJ, Bobes-Bascaran T, Hyde TM, Kleinman JE, Herman MM, Chen S, et al. 2014. APOE2 enhances neuroprotection against Alzheimer's disease through multiple molecular mechanisms. Mol Psychiatry 19:1243–1250.
  • Corbo RM, Scacchi R. 1999. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele? Ann Hum Genet 63:301–310.
  • Corbo RM, Scacchi R, Mureddu L, Mulas G, Alfano G. 1995. Apolipoprotein E polymorphism in Italy investigated in native plasma by a simple polyacrylamide gel isoelectric focusing technique. Comparison with frequency data of other European populations. Ann Hum Genet 59:197–209.
  • Csajbok LZ, Nylen K, Ost M, Blennow K, Zetterberg H, Nellgard P, Nellgard B. 2016. Apolipoprotein E polymorphism in aneurysmal subarachnoid haemorrhage in West Sweden. Acta Neurol Scand 133:466–474.
  • Cumming AM, Robertson FW. 1984. Polymorphism at the apoprotein-E locus in relation to risk of coronary disease. Clin Genet 25:310–313.
  • de-Almada BV, de-Almeida LD, Camporez D, de-Moraes MV, Morelato RL, Perrone AM, Belcavello L, et al. 2012. Protective effect of the APOE-e3 allele in Alzheimer's disease. Braz J Med Biol Res 45:8–12.
  • Deiana L, Pes GM, Carru C, Errigo A, Pettinato S, Carcassi C, Baggio G, Contu L. 1998. Lack of influence of apolipoprotein E4 on lipoprotein levels in the island population of Sardinia. Eur J Clin Invest 28:290–294.
  • de Knijff P, Boomsma DI, de Wit E, Kempen HJ, Gevers Leuven JA, Frants RR, Havekes LM. 1993. The effect of the apolipoprotein E phenotype on plasma lipids is not influenced by environmental variability: results of a Dutch twin study. Hum Genet 91:268–272.
  • Eisenberg DT, Kuzawa CW, Hayes MG. 2010. Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history. Am J Phys Anthropol 143:100–111.
  • El-Lebedy D, Raslan HM, Mohammed AM. 2016. Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease. Cardiovasc Diabetol 15:12.
  • European Commission – Trade – Countries and regions – Western Balkans 2017. Available from: http://ec.europa.eu/trade/policy/countries-and-regions/regions/western-balkans/ (accessed September 12, 2016).
  • Fullerton SM, Clark AG, Weiss KM, Nickerson DA, Taylor SL, Stengard JH, Salomaa V, et al. 2000. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet 67:881–900.
  • Gerdes LU, Klausen IC, Sihm I, Faergeman O. 1992. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 9:155–167.
  • Gialeraki A, Politou M, Rallidis L, Merkouri E, Markatos C, Kremastinos D, Travlou A. 2008. Prevalence of prothrombotic polymorphisms in Greece. Genet Test 12:541–547.
  • Gueguen R, Visvikis S, Steinmetz J, Siest G, Boerwinkle E. 1989. An analysis of genotype effects and their interactions by using the apolipoprotein E polymorphism and longitudinal data. Am J Hum Genet 45:793–802.
  • Haddy N, De Bacquer D, Chemaly MM, Maurice M, Ehnholm C, Evans A, Sans S, et al. 2002. The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe. Eur J Hum Genet 10:841–850.
  • Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, Utermann G. 1991. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 49:338–349.
  • Kalina A, Szalai C, Prohaszka Z, Reiber I, Csaszar A. 2002. Association of plasma lipid levels with apolipoprotein E polymorphism in Type 2 diabetes. Diabetes Res Clin Pract 56:63–68.
  • Kaya G, Gunduz E, Acar M, Hatipoglu OF, Acar B, Ilhan A, Gunduz M. 2015. Potential genetic biomarkers in the early diagnosis of Alzheimer disease: APOE and BIN1. Turk J Med Sci 45:1058–1072.
  • Kim KW, Jhoo JH, Lee KU, Lee DY, Lee JH, Youn JY, Lee BJ, et al. 1999. Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans. Neurosci Lett 277:145–148.
  • Klasen EC, Smit M, de Kniff P, Gevers Leuven J, Kempen-Voogd R, Havekes L. 1987. Apolipoprotein E phenotype and gene distribution in The Netherlands. Hum Hered 37:340–344.
  • Kovacevic L, Tambets K, Ilumae AM, Kushniarevich A, Yunusbayev B, Solnik A, Bego T, et al. 2014. Standing at the gateway to Europe-the genetic structure of Western balkan populations based on autosomal and haploid markers. PLoS One 9:e105090.
  • Kowalska A, Wiechmann I, Walter H. 1998. Genetic variability of apolipoprotein E in a Polish population. Hum Biol 70:1093–1099.
  • Lehtimaki T, Uibu T, Roto P, Koivula T, Jokela H, Ehnholm C, Peltonen N, Nikkari T. 1998. Apolipoprotein E and A-IV polymorphisms in the Estonian population. Clin Genet 54:106–107.
  • Letonja M, Guzic-Salobir B, Peterlin B, Petrovic D. 2004. Apolipoprotein E gene polymorphism effects triglycerides but not CAD risk in Caucasian women younger than 65 years. Ann Genet 47:147–153.
  • Lucotte G, Loirat F, Hazout S. 1997. Pattern of gradient of apolipoprotein E allele *4 frequencies in western Europe. Hum Biol 69:253–262.
  • Luptakova L, Sivakova D, Cvicelova M, Wsolova L, Dankova Z, Michnova A, Blazicek P. 2013. Power of biomarkers and their relative contributions to metabolic syndrome in Slovak adult women. Ann Hum Biol 40:132–138.
  • Marjanovic D, Fornarino S, Montagna S, Primorac D, Hadziselimovic R, Vidovic S, Pojskic N, et al. 2005. The peopling of modern Bosnia-Herzegovina: Y-chromosome haplogroups in the three main ethnic groups. Ann Hum Genet 69:757–763.
  • Masic I, Dilic M, Raljevic E, Vulic D, Mott D. 2010. Trends in cardiovascular diseases in Bosnia and Herzegovina and perspectives with heartscore programme. Med Arh 64:260–263.
  • Masson LF, McNeill G, Avenell A. 2003. Genetic variation and the lipid response to dietary intervention: a systematic review. Am J Clin Nutr 77:1098–1111.
  • Mouros M, Rodriguez-Ferrer C. 1996. Apolipoprotein E polymorphism infuence in lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apoE4. Atherosclerosis 121:13–21.
  • Mustapic M, Popovic Hadzija M, Pavlovic M, Pavkovic P, Presecki P, Mrazovac D, Mimica N, et al. 2012. Alzheimer's disease and type 2 diabetes: the association study of polymorphisms in tumor necrosis factor-alpha and apolipoprotein E genes. Metab Brain Dis 27:507–512.
  • Nagy B, Karadi I, Fintor L, Rigo J, Jr, Romics L, Papp Z. 1999. Apolipoprotein E gene polymorphism frequencies in a sample of healthy Hungarians. Clin Chim Acta 282:147–150.
  • Nagy B, Rigo J, Jr, Fintor L, Karadi I, Toth T. 1998. Apolipoprotein E alleles in women with severe pre-eclampsia. J Clin Pathol 51:324–325.
  • Oria RB, Patrick PD, Blackman JA, Lima AA, Guerrant RL. 2007. Role of apolipoprotein E4 in protecting children against early childhood diarrhea outcomes and implications for later development. Med Hypotheses 68:1099–1107.
  • Pedersen JC, Berg K. 1989. Interaction between low density lipoprotein receptor (LDLR) and apolipoprotein E (apoE) alleles contributes to normal variation in lipid level. Clin Genet 35:331–337.
  • Pedersen JC, Berg K. 1990. Gene-gene interaction between the low density lipoprotein receptor and apolipoprotein E loci affects lipid levels. Clin Genet 38:281–294.
  • Petkeviciene J, Smalinskiene A, Luksiene DI, Jureniene K, Ramazauskiene V, Klumbiene J, Lesauskaite V. 2012. Associations between apolipoprotein E genotype, diet, body mass index, and serum lipids in Lithuanian adult population. PLoS One 7:e41525.
  • Petrovic D, Zorc M, Peterlin B. 2000. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease. Folia Biol (Praha) 46:181–185.
  • Rall SC, Jr, Weisgraber KH, Mahley RW. 1982. Human apolipoprotein E. The complete amino acid sequence. J Biol Chem 257:4171–4178.
  • Sajantila A, Salem AH, Savolainen P, Bauer K, Gierig C, Paabo S. 1996. Paternal and maternal DNA lineages reveal a bottleneck in the founding of the Finnish population. Proc Natl Acad Sci USA 93:12035–12039.
  • Schmidt R, Schmidt H, Fazekas F, Schumacher M, Niederkorn K, Kapeller P, Weinrauch V, Kostner GM. 1997. Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. Stroke 28:951–956.
  • Seldin MF, Shigeta R, Villoslada P, Selmi C, Tuomilehto J, Silva G, Belmont JW, et al. 2006. European population substructure: Clustering of northern and southern populations. PLoS Genet 2:e143.
  • Seripa D, Matera MG, Daniele A, Bizzarro A, Rinaldi M, Gravina C, Bisceglia L, et al. 2007. The missing ApoE allele. Ann Hum Genet 71:496–500.
  • Sheehan D, Bennett T, Cashman K. 2000. Apolipoprotein E gene polymorphisms and serum cholesterol in healthy Irish adults: a proposed genetic marker for coronary artery disease risk. Ir J Med Sci 169:50–54.
  • Sima A, Iordan A, Stancu C. 2007. Apolipoprotein E polymorphism-a risk factor for metabolic syndrome. Clin Chem Lab Med 45:1149–1153.
  • Sivakova D, Zacharova M, Gasparovic J, Raslova K, Wsolova L, Basistova Z, Blazicek P. 2006. Apolipoprotein E polymorphism in relation to plasma lipid levels and other risk factors of atherosclerosis in two ethnic groups from Slovakia. Coll Antropol 30:387–394.
  • Sklavounou E, Economou-Petersen E, Karadima G, Panas M, Avramopoulos D, Varsou A, Vassilopoulos D, Petersen MB. 1997. Apolipoprotein E polymorphism in the Greek population. Clin Genet 52:216–218.
  • United Nations Statistics Division- Standard Country and Area Codes Classifications 1999. Available from: http://unstats.un.org/unsd/methods/m49/m49regin.htm#europe (accessed September 12, 2016).
  • Valveny N, Esteban E, Kandil M, Moral P. 1997. APO E polymorphism in Spanish and Moroccan populations. Clin Genet 51:354–356.
  • Vucinic N, Djan I, Stokic E, Bozzn B, Obreht D, Stankov K, Djan M. 2014. Different associations of apoE gene polymorphism with metabolic syndrome in the Vojvodina Province (Serbia). Mol Biol Rep 41:5221–5227.
  • Wozniak MA, Shipley SJ, Dobson CB, Parker SP, Scott FT, Leedham-Green M, Breuer J, Itzhaki RF. 2007. Does apolipoprotein E determine outcome of infection by varicella zoster virus and by Epstein Barr virus?. Eur J Hum Genet 15:672–678.
  • Zurnic I, Djuric T, Koncar I, Stankovic A, Dincic D, Zivkovic M. 2014. Apolipoprotein E gene polymorphisms as risk factors for carotid atherosclerosis. Vojnosanit Pregl 71:362–367.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.